WT

Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of her annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earliest of (i) January 1, 2029, (ii) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (iii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of her annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earliest of (i) June 30, 2027, (ii) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (iii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of her annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earlier of (i) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (ii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.

Restricted stock units ("RSUs") issued to the Reporting Person pursuant to the Non-Employee Directors' Deferred Compensation Program under the 2022 Equity Plan. In accordance with an election made by the Reporting Person to defer receipt of his annual restricted stock award, the common stock underlying the RSUs will vest on June 17, 2027, and is payable on a one-for-one basis (one share of common stock for each RSU) upon the earlier of (i) a "separation from service" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended (Code)) and (ii) a Sale Event (as defined in the 2022 Equity Plan) so long as such Sale Event also constitutes a "change in the ownership or effective control" or a "change in the ownership of a substantial portion of the assets" of the Issuer (as such terms are defined in Code Section 409A).

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 24, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. All sales by the reporting person are subject to the Issuer's equity ownership requirements.

Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

The price included in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $19.25 to $19.34, inclusive. The reporting person undertakes to provide to WisdomTree, Inc., any security holder of WisdomTree, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.

Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

Includes restricted stock awards vesting as to (i) 35,859 shares on January 25, 2027, (ii) 19,116 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 24, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. All sales by the reporting person are subject to the Issuer's equity ownership requirements.

Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer.

Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

On January 25, 2026, the Compensation Committee of the Issuer's Board of Directors approved a grant of performance-based restricted stock units ("PRSUs") initially reported on a Form 4 filed January 27, 2026 and amended February 24, 2026 ("Prior Form 4"), with the target number of PRSUs determined based on the grant-date fair value calculated using a Monte Carlo valuation methodology. On February 23, 2026, the Compensation Committee approved a change in the methodology for determining PRSU target shares to one based on the Issuer's grant date closing stock price and, in connection with that change, approved a separate, additional grant of PRSUs to the Reporting Person equal to the difference between (i) the target number of PRSUs reported in the Prior Form 4 and (ii) the target number of PRSUs determined using the Issuer's closing stock price on January 25, 2026. This grant is intended to qualify for the Rule 16b-3 exemption under the Securities Exchange Act of 1934.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each unit that vests.

These PRSUs are scheduled to vest on February 23, 2029. The target number of PRSUs is reported on this form. Between 0% and 200% of the target number of PRSUs may vest and the number of shares of the Issuer's common stock ("Common Stock") to be issued will be determined based on the total shareholder return ("TSR") of the Common Stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date. If the Reporting Person's employment is terminated under certain circumstances or a change of control occurs prior to the 3rd anniversary of the grant date, all or a portion of the PRSUs will vest and the number of shares of Common Stock to be issued will be determined at such time based on the respective TSRs of the Common Stock and the stock of the peer group, each measured from the grant date to the accelerated vesting date.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 24,096 PRSUs between the grant date and vesting date.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 37,773 shares on January 25, 2027, (ii) 19,365 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 35,859 shares on January 25, 2027, (ii) 19,116 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,908 PRSUs between the grant date and vesting date.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 24,096 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 189,055 shares on January 25, 2027, (ii) 99,253 shares on January 25, 2028 and (iii) 40,439 shares on January 25, 2029.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,586 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 35,859 shares on January 25, 2027, (ii) 19,116 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 2,555 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 189,055 shares on January 25, 2027, (ii) 99,253 shares on January 25, 2028 and (iii) 40,439 shares on January 25, 2029.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,908 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 60,394 shares on January 25, 2027, (ii) 33,526 shares on January 25, 2028 and (iii) 14,777 shares on January 25, 2029.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 60,394 shares on January 25, 2027, (ii) 33,526 shares on January 25, 2028 and (iii) 14,777 shares on January 25, 2029.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 51,943 shares on January 25, 2027, (ii) 28,277 shares on January 25, 2028 and (iii) 10,538 shares on January 25, 2029.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 55,049 shares on January 25, 2027, (ii) 30,942 shares on January 25, 2028 and (iii) 12,016 shares on January 25, 2029.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,669 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 37,773 shares on January 25, 2027, (ii) 19,365 shares on January 25, 2028 and (iii) 7,564 shares on January 25, 2029.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 44,646 shares on January 25, 2027, (ii) 22,733 shares on January 25, 2028 and (iii) 8,619 shares on January 25, 2029.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 55,049 shares on January 25, 2027, (ii) 30,942 shares on January 25, 2028 and (iii) 12,016 shares on January 25, 2029.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 14,710 PRSUs between the grant date and vesting date.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 2,555 PRSUs between the grant date and vesting date.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,669 PRSUs between the grant date and vesting date.

Shares withheld by the Issuer upon vesting of PRSUs to cover withholding taxes.

Includes restricted stock awards vesting as to (i) 51,943 shares on January 25, 2027, (ii) 28,277 shares on January 25, 2028 and (iii) 10,538 shares on January 25, 2029.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,838 PRSUs between the grant date and vesting date.

These PRSUs were granted by the Issuer on January 25, 2023 and vested on January 25, 2026. The ultimate number of shares that could have vested was between 0 and 200% of the previously reported target number of PRSUs based on the total shareholder return ("TSR") of the Issuer's common stock relative to the respective TSRs of the stocks of a peer group of companies, each measured over a 3-year period from the grant date ("Relative TSR"). Based on a report issued by an independent valuation specialist and certified by the Issuer's compensation committee on January 27, 2026, the Relative TSR measured in the 84.62nd percentile, resulting in the vesting of 199% of the target number of PRSUs.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 1,586 PRSUs between the grant date and vesting date.

Each performance-based restricted stock unit ("PRSU") represented the right to receive, on the vesting date, one share of common stock for each such unit that vested.

Includes the reinvestment of dividend equivalents into 14,710 PRSUs between the grant date and vesting date.

Includes restricted stock awards vesting as to (i) 114,570 shares on January 25, 2027, (ii) 59,724 shares on January 25, 2028 and (iii) 23,785 shares on January 25, 2029.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.

Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.